Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about SolidBiosciencesInc-2021-03-18
$143.7 Million
Image
Solid Biosciences Inc.
Follow-On Offering
Active Bookrunner
Read more
about ESSAPharmaInc-2021-02-17
$149.9 Million
Image
ESSA Pharma Inc.
Follow-On Offering
Active Bookrunner
Read more
about NurixInc-2021-03-04
$160.4 Million
Image
Nurix Inc.
Follow-On Offering
Active Bookrunner
Read more
about TCR2Therapeutics-2021-01-19
$140.0 Million
Image
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about CytomXTherapeuticsInc-2021-01-20
$114.9 Million
Image
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
Read more
about OncorusInc-2021-02-11
$57.0 Million
Image
Oncorus, Inc.
Follow-On Offering
Active Bookrunner
Read more
about DyneTherapeuticsInc-2021-01-20
$168.0 Million
Image
Dyne Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about AmericanWellCorporation-2021-01-14
$356.7 Million
Image
American Well Corporation
Follow-On Offering
Active Bookrunner
Read more
about Arvinas-2020-12-15
$459.9 Million
Image
Arvinas
Follow-On Offering
Active Bookrunner
Read more
about OcularTherapeutixInc-2020-12-15
$92.1 Million
Image
Ocular Therapeutix, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 18
Next page
››
Subscribe to Active Bookrunner